The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksShire Share News (SHP)

  • There is currently no data for SHP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 1-FTSE rises to 4-week high helped by sterling weakness

Thu, 27th Sep 2018 17:53

* FTSE 100 up 0.5 pct

* Higher crude lifts oil stocks, hits airlines

* TUI sticks to forecasts, shares gain(Adds details, closing prices)

By Danilo Masoni

MILAN, Sept 27 (Reuters) - Britain's top share index rose onThursday to a four-week high, helped by a drop in sterling,while continued weakness in basic materials stocks weighed.

The FTSE 100 gained 0.5 percent as the pound washeld back by strength in the dollar following a U.S. rate hikeand investors remained nervous on the outcome of Brexit talks.

The index, whose companies make around 70 percent of theirtotal earnings from overseas, slightly outperformed the broaderEuropean market, which was weighed down by worries over Italy'sbudget.

Among the top FTSE gainers were tobacco group BAT,spirits maker Diageo and drugmaker Shire, whichall rose more than 1 percent.

Oil and gas stocks rose as crude prices werepushed higher by the prospect of tighter markets due to U.S.sanctions against major oil exporter Iran.

"Unless the U.S. releases reserves or OPEC commits tofurther output to plug the gap, oil could continue to crankhigher from here," said Markets.com analyst Neil Wilson.

Oil major BP was the biggest gainer in the sector, up1.2 percent, while Shell eased 0.1 percent.

Airlines suffered from the strength in crude prices.

EasyJet fell 2.6 percent, further hit by a pricetarget cut from Kepler Cheuvreux. British Airways owner IAGfell 0.6 percent but Ryanair added 0.3 percent.

Travel operator TUI rose 2.5 percent after thecompany said it was on track to meet its forecasts for earningsgrowth, shrugging off the impact of a hot summer in its maincustomer markets.

TUI rival Thomas Cook, which cut its profit forecastthis week blaming a heatwave in Europe, gained 1.6 percent.

"The nature of TUI's tour operating business, which is lessexposed to the late booking market where Thomas Cook suffered,and its greater exposure to the high growth and high margincruise ship business have helped the former perform better,"said Russ Mould, investment director at AJ Bell.

Miners were broadly lower as copper prices fell further. Thesector was the biggest weight to the FTSE on Thursday.

Mid-cap IG Group was a stand-out faller, down 12.8percent, after the online financial trading firm said its CEOPeter Hetherington would step down immediately.

Rival CMC Markets fell 2.2 percent. Both stockshave recently suffered sharp share price falls after weakresults and amid tighter regulatory scrutiny.

Shares of Indivior fell sharply for a secondstraight day, down 13 percent, as prospects for the Britishdrugmaker's new potential blockbuster drug waned.

(Reporting by Danilo Masoni; Editing by Gareth Jones and RobinPomeroy)

More News
24 Aug 2018 11:54

LONDON MARKET MIDDAY: Stocks Up; Powell To Make Jackson Hole Debut

LONDON (Alliance News) - Stocks in London were marginally higher at midday on Friday ahead of a highly anticipated speech from the head of the US Federal Reserve.With US-China trade talks demoting a

Read more
24 Aug 2018 10:39

WINNERS & LOSERS SUMMARY: Shire Rises As US FDA Approves Takhzyro Drug

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Friday.----------FTSE 100 - up 2.6%. The Irish pharmaceutical company said a

Read more
24 Aug 2018 08:38

LONDON MARKET OPEN: Stocks Mixed, Shire Rises After Drug Approval

LONDON (Alliance News) - Stock prices in London were mixed early Friday, as markets await US Federal Reserve Chair Jerome Powell's speech in Wyoming later in the day. In the large cap index rose

Read more
24 Aug 2018 08:06

FDA gives nod to Shire's TAKHZYRO treatment

(Sharecast News) - Shire announced on Friday that, following priority review, the US Food and Drug Administration (FDA) has approved the 'TAKHZYRO' (lanadelumab-flyo) injection for prophylaxis to prevent attacks of hereditary angioedema (HAE) in patients 12 years of age and older.

Read more
24 Aug 2018 07:41

LONDON MARKET PRE-OPEN: Slightly Lower Call Ahead Of Powell Speech

LONDON (Alliance News) - Stock prices in London are seen lower on Friday ahead of US Federal Reserve Chair Jerome Powell's speech later during the day, while in a quiet day for UK company news In

Read more
13 Aug 2018 10:31

WINNERS & LOSERS SUMMARY: Chemring Says Fatal Accident To Hurt Profit

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Monday.----------FTSE 100 - WINNERS----------BAE up 0.8%. a

Read more
13 Aug 2018 09:21

Shire Partner Shionogi Files New Drug Application For Intuniv In Japan

LONDON (Alliance News) - Irish drugmaker Shire PLC said on Monday its Japanese partner Shionogi & Co Ltd has submitted a new drug application for the manufacture and marketing of Intuniv in is

Read more
13 Aug 2018 07:51

Shire and Shionogi apply to expand ADHD treatment to adults

(Sharecast News) - Shire and Shionogi have applied to expand the use in Japan of co-developed drug Intuniv to treat adults for attention deficit hyperactivity disorder.

Read more
31 Jul 2018 12:51

TOP NEWS: Shire Income Up In 2nd-Quarter Ahead Of Takeover By Takeda

LONDON (Alliance News) - Irish biotechnology company Shire PLC on Tuesday posted a more than doubled pretax income in the second quarter, ahead of its upcoming takeover by Takeda Pharmaceutical Co

Read more
31 Jul 2018 12:12

Shire posts 4 pct rise in Q2 earnings ahead of sale to Takeda

LONDON, July 31 (Reuters) - Shire, the London-listed pharmaceutical group being bought by Japan's Takeda, reported a 4 percent rise in second-quarter earnings as revenue rose 5 percent to just

Read more
31 Jul 2018 12:08

Shire's quarterly sales rise on immunology demand

(Sharecast News) - Shire reported healthy sales growth in the second quarter as the biotech company pressed ahead with its acquisition by Takeda of Japan.

Read more
31 Jul 2018 08:05

UPDATE 1-Takeda posts weakest Q1 profit in three years

* Q1 operating profit Y98.9 bln vs Y195 bln a year earlier * Takeda booked gains from asset sales a year earlier (Adds details) TOKYO, July 31 (Reuters) - Japan's Takeda Co Ltd a

Read more
25 Jul 2018 07:00

RPT-ANALYSIS-Buy yen in crisis? Not this year

* Yen weakest G10 currency this month despite global turbulence * Investors doubt BOJ can reduce stimulus aggressively * Japanese purchases of foreign equities highest in nearly Bond

Read more
24 Jul 2018 16:06

UK Earnings, Trading Statements Calendar - Next 7 Days

Wednesday 25 July GlaxoSmithKlineHalf Year Results (at 1200 BST)Vodafone GroupTrading 26

Read more
24 Jul 2018 15:08

ANALYSIS-Buy yen in crisis? Not this year

* Yen weakest G10 currency this month despite global turbulence * Investors doubt BOJ can reduce stimulus aggressively * Japanese purchases of foreign equities highest in nearly Bond

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.